NABL ACCREDITED LABORATORY

PANEL
SAMPLE NO
:
:
KANAK NURSING HOME
02/2025/468 OSS *P0140727*
PATIENT NAME : LAKSHI CHAKRABORTY ID NO. : L0140727
SEX / AGE : MALE / 62 Y RECEIPT DATE : 10/02/2025
REFERRED BY : Dr. A PAUL REPORT DATE : 10/02/2025

BIOCHEMISTRY

Test Name Result Unit Reference Range

SERUM UREA 17 mg / dl 10 - 45
Methodology: Berthelot Method
Specimen : serum

A common blood test, the blood urea nitrogen (BUN) test reveals important information about how well your kidneys and liver
are working. A BUN test measures the amount of urea nitrogen that is in your blood .

SERUM CREATININE 0.86 mg/dl 0.6 - 1.5

Methodology: JAFFE Modified Method
Specimen : Serum

INSTRUMENT USED: TRANSASIA EM200 FULLAUTO ANALYZER

A creatinine test reveals important information about your kidneys . Creatinine is a chemical waste product that is produced
by your muscle metabolism and to a smaller extent by eating meat. Healthy kidneys filter creatinine and other waste products
from your blood. The filtered waste products leave your body in your urine.If your kidneys are not functioning properly, an
increased level of creatinine may accumulate in your blood. A serum creatinine test measures the level of creatinine in your
blood and provides an estimate of how well your kidneys filter (glomerular filtration rate). A creatinine urine test can measure
creatinine in your urine.
NA+ , K+
ELECTROLYTE ANALYZER
(SODIUM,POTASSIUM)

SODIUM 137 moml/L 135-145

POTASSIUM 4.8 mmol/L 3.5-5.5

SAMPA
Checked By
DR. S. Bose DR. Swarnendu Pal Dr Sonali Banerjee

MBBS. DCP M.B.B.S., M.D. M.B.B.S., M.D. NABL-M(EL)T-02711

Consultant Histopathologiest & Cytologist Consultant Histopathologist & Cytologist Consultant BioChemist
 NABL ACCREDITED LABORATORY

PANEL
SAMPLE NO
:
:
KANAK NURSING HOME
02/2025/468 OSS *P0140727*
PATIENT NAME : LAKSHI CHAKRABORTY ID NO. : L0140727
SEX / AGE : MALE / 62 Y RECEIPT DATE : 10/02/2025
REFERRED BY : Dr. A PAUL REPORT DATE : 10/02/2025
Interpretation:
SERUM SODIUM Measurement of serum sodium is routine in assessing electrolyte, acid-base, and water balance, and renal
function. Sodium accounts for approximately 95% of the osmotically active substances in the extracellular compartment,
provided the patient is not in renal failure or has severe hyperglycemia. The reference range for serum sodium is 135-145
mmol/L. Conditions associated with increased serum sodium (hypernatremia) include the following:
Decreased total body water (impaired thirst, restricted access to water, increased fluid loss, diabetes insipidus (DI)
Mineralocorticoid excess (hyperaldosteronism, Cushing disease, Conn syndrome)
Conditions associated with decreased serum sodium (hyponatremia) include the following:
Hypervolemic (cirrhosis, heart failure, nephrotic syndrome)
Euvolemic (CNS disorders [eg, brain trauma], syndrome of inappropriate antidiuretic hormone [SIADH], severe nausea or
pain) Hypovolemic (increased fluid loss, diuretic use) Other (hypothyroidism, adrenal insufficiency, primary polydipsia)

SERUM POTASSIUM is an electrolyte, which is a mineral in the blood that can be measured by a blood test. Potassium is
ingested through food and electrolyte-enhanced beverages and excreted primarily through urine.The reference ranges of
serum/plasma potassium levels are as follows:
Adults: 3.5-5.5 mEq/L or mmol/L
Children: 3.4-4.7 mEq/L or mmol/L (age dependent)
The reference ranges of urinary potassium levels are as follows :
Adults: 25-125 mEq/L/day
Children: 10-60 mEq/L/day
Results can be affected by infusion of potassium-containing fluids or an infusion of glucose or insulin.Conditions associated
with high potassium values include the following:
Hyperkalemia,Blood transfusion,Hemolytic anemia (red cell destruction),Acute renal failure,Addison
disease,Hypoaldosteronism,Tissue injury,Eating disorders (anorexia, bulimia),
Infection,Diabetic ketoacidosis,Dehydration,Excessive potassium intake (dietary or intravenous),Magnesium deficiency ETC

LIVER FUNCTION TEST

*Alkaline phosphate for children & teenagers during bone growth are higher than for adults.

INSTRUMENT USED: TRANSASIA EM200 FULLAUTO ANALYZER

(LFT)

Billirubin Total 0.27 mg/dL UP TO 1.20

Billirubin Direct 0.13 mg/dL UP TO 0.20
Billirubin Indirect 0.14 mg/dL
Total Protein 6.70 gm/dl 6.3-8.4
Albumin 3.92 gm/dl 3.5-5.0
Globulin 2.78 gm/dl 2.3-3.6
A:G Ratio 1.41:1
Alkaline Phosphatase(ALP), Total 99 IU/L ADULT MALE:44.0-132.0 AT
37 C.
ADULT FEMALE: 44.0-147.0
AT 37 C.
CHILDREN BETWEEN 10-17
YRS. 50-350
SGPT / ALT 21 IU/L 5-45
SGOT / AST 26 IU/L 5-45

SAMPA
Checked By
DR. S. Bose DR. Swarnendu Pal Dr Sonali Banerjee

MBBS. DCP M.B.B.S., M.D. M.B.B.S., M.D. NABL-M(EL)T-02711

Consultant Histopathologiest & Cytologist Consultant Histopathologist & Cytologist Consultant BioChemist
 NABL ACCREDITED LABORATORY

PANEL
SAMPLE NO
:
:
KANAK NURSING HOME
02/2025/468 OSS *P0140727*
PATIENT NAME : LAKSHI CHAKRABORTY ID NO. : L0140727
SEX / AGE : MALE / 62 Y RECEIPT DATE : 10/02/2025
REFERRED BY : Dr. A PAUL REPORT DATE : 10/02/2025
Premature: 0-1day<8.0
1-2days<12.0
3-5days<16.0
Above 5days 0.3-1.2

GLYCOSYLATE HAEMOGLOBIN (HbA1c)

GLYCOSYLATE HAEMOGLOBIN BY HPLC

HbA1c (Glycated Haemoglobin) 6.6 % Normal Glucose tolerance

(nondiabetic):
<5.6%~Pre-diabetic:
5.7-6.4%~Diabetic Mellitus:
>6.5%
Estimated Average Blood Glucose (EAG) 141.285 mg/dl

SAMPA
Checked By
DR. S. Bose DR. Swarnendu Pal Dr Sonali Banerjee

MBBS. DCP M.B.B.S., M.D. M.B.B.S., M.D. NABL-M(EL)T-02711

Consultant Histopathologiest & Cytologist Consultant Histopathologist & Cytologist Consultant BioChemist
 NABL ACCREDITED LABORATORY

PANEL
SAMPLE NO
:
:
KANAK NURSING HOME
02/2025/468 OSS *P0140727*
PATIENT NAME : LAKSHI CHAKRABORTY ID NO. : L0140727
SEX / AGE : MALE / 62 Y RECEIPT DATE : 10/02/2025
REFERRED BY : Dr. A PAUL REPORT DATE : 10/02/2025
===============================================================================================
=======================
Introduction:
--------------------------------------------------------------------------------------------------------------------------------------------------------------------
---------------------------------------------
Haemoglobin A1c In the blood stream are the red blood cells, which are made of a molecule, haemoglobin.Glucose s
cks to the
haemoglobin to make a ''''''''''''''''''''''''''''''''glycosylated haemoglobin molecule, called haemoglobinA1c or HbA1c. The more
glucose in the blood, the more haemoglobin
A1c or HbA1c will be present in the blood.HbA1C is an indicator of glycemic control.HbA1c represents average glycemia over
the past six to eight
weeks.Glyca on of hemoglobin occurs over the en
re 120 days life span of the red blood cell , but within this 120 days.Recent glycemia has the largest
influence on the HbA1c value .Clinical Studies suggest that a pa
ent in stable control will have 50 % of their HbA1c formed in the month before
sampling , 25 % in the before that , and the remaing 25 % in months two to four.
Underlying Principle:In the normal 120-day life span of the RBC, glucose molecules join haemoglobin, forming glycosylated
haemoglobin. In individuals
with poorly controlled diabetes, increases in the quan
es of this glycosylated haemoglobin are noted. Once a haemoglobin molecule is glycosylated,
it remains that way. A buildup of glycosylated haemoglobin within the red
cell reflects the average level of glucose to which the cell has been exposed
during its life cycle. Measuring glycosylated haemoglobin assesses the effec veness of therapy by monitoring long-term
serum glucose
regulation.HbA1c levels depend on the blood glucose concentra on. That is, the higher the glucose concentra
on in blood, the higher of the level of
HbA1c; and is not influenced by daily fluctua on in the blood glucose concentra on
but reflects the average levels over the prior two or three months.
Therefore,
HbA1c is a useful indicator of how well the blood glucose level has been controlled in the recent past and may be used to mo
nitor the effects
of diet, exercise and drug therapyon blood glucose in diabetic patients.
Healthy HbA1c levels: Target HbA1c levels may very from person to person.
--------------------------------------------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------

N.B:-.Reference values represent statistical data for 95% of the population , values outside of these ranges do not
necessarily represent disease rather than classification of patient’s as having disease or being healthy .These reference
may vary depending on the individual laboratory as well as the methods and instruments used . each clinician should
compare the applicability of these data to their own situation .Individual tests are normal in high proportions of patients
with proven specific disease & normal values may not rule out disease .

ALL BLOOD SAMPLES ARE STORED FOR 2 DAYS FROM DATE OF COLLECTION OF SAMPLES. IN CASE OF ANY
DISCREPANCIES REGARDING REPORT PLEASE CONTACT LAB IMMEDIATELY WITHIN 2 DAYS FOR RE-TEST AND
CLARIFICATIONS.

SAMPA
Checked By
DR. S. Bose DR. Swarnendu Pal Dr Sonali Banerjee

MBBS. DCP M.B.B.S., M.D. M.B.B.S., M.D. NABL-M(EL)T-02711

Consultant Histopathologiest & Cytologist Consultant Histopathologist & Cytologist Consultant BioChemist
 NABL ACCREDITED LABORATORY

PANEL
SAMPLE NO
:
:
KANAK NURSING HOME
02/2025/468 OSS *P0140727*
PATIENT NAME : LAKSHI CHAKRABORTY ID NO. : L0140727
SEX / AGE : MALE / 62 Y RECEIPT DATE : 10/02/2025
REFERRED BY : Dr. A PAUL REPORT DATE : 10/02/2025

HEMATOLOGY

Test Name Result Unit Reference Range

COMPLETE HAEMOGRAM
Specimen: EDTA Whole blood
AUTOMATED CELL COUNTER USED

HAEMOGLOBIN
HB% 11.8 Gm/dl ADULT MALE: 13 - 17
ADULT FEMALE: 12 - 15
TOTAL COUNT

ERYTHROCYTE 3.93 million/cu. MALE: 4.5 - 5.5

mm FEMALE ; 3.8 - 4.8
LEUCOCYTE 4400 Count/c.mm 4000-10000
PLATELET (DC detection method/manual) 0.90 Lakhs/c.mm 1.5 - 4.0
DIFFERENTIAL LEUCOCYTES COUNT
(MANUAL)
NEUTROPHIL 54 % 40 - 80
LYMPHOCYTE 42 % 20 - 40
MONOCYTE 01 % 2 - 10
EOSINOPHIL 03 % 1-6
BASOPHIL 00 % <1-2
E.S.R. (WESTERGREN)

FIRST HOURS 39 mm. 5 - 20

P/S MORPHOLOGY

MORPHOLOGY OF RBC NORMOCYTIC NORMOCHROMIC.

MORPHOLOGY OF WBC NO ABNORMAL CELL DETECTED IN LEUKOCYTES SERIES
.

(P.C.V) 34.6 % MALE : 40 - 50

FEMALE : 36 - 46
(M.C.V) 88.0 fL 83 - 101
(M.C.H) 30.0 pg 27 - 32Pg
(M.C.H.C) 34.1 gm/dL 31.5 - 34.5
RDW(CV) 14.2 % 11.6 - 14.0

ALL REFERENCE RANGE : FOR ADULTS ONLY

Note: Platelet value rechecked manually. Pre-analytical factors may affect values, specially low values. Correlate
clinically

SAMPA
Checked By
DR. S. Bose DR. Swarnendu Pal Dr Sonali Banerjee

MBBS. DCP M.B.B.S., M.D. M.B.B.S., M.D. NABL-M(EL)T-02711

Consultant Histopathologiest & Cytologist Consultant Histopathologist & Cytologist Consultant BioChemist
 NABL ACCREDITED LABORATORY

PANEL
SAMPLE NO
:
:
KANAK NURSING HOME
02/2025/468 OSS *P0140727*
PATIENT NAME : LAKSHI CHAKRABORTY ID NO. : L0140727
SEX / AGE : MALE / 62 Y RECEIPT DATE : 10/02/2025
REFERRED BY : Dr. A PAUL REPORT DATE : 10/02/2025

IMMUNOLOGICAL TEST

Test Name Result Unit Reference Range

TSH(Thyroid Stimulating Hormone) 3.27 µIU/ml Adult: 0.39 - 6.16

<3 Days: 3.20 - 34.60
3 - 4 Days: 0.70 - 15.40
5 Days to 5 Months: 1.70 -
9.10
5 Months to 12 Years: 0.70 -
6.4
Secimen: Serum

FOR PREGNENT WOMEN:

1ST TRIMESTER 0.10 - 2.50 µIU/ml
2ND TRIMESTER 0.20 - 3.00 µIU/ml
3RD TRIMESTER 0.30 - 3.00 µIU/ml

Interpretation(s)
Use:
TSH controls the biosynthesis and release of thyroid hormones T 4 and T3. It is a sensitive measure of thyroid function,
especially useful in early or subclinical hypothyroidism before the patient develops clinical findings, goiter, or abnormalities of
other thyroid tests. And in monitoring of adequate thyroid hormone replacement therapy in primary hypothyroidism, although
T4 may be mildly increased.

Decreased Levels:
Toxic Multinodular Goitre, Thyroiditis, Overreplacement of thyroid hormone in treatment of hypothyroidism, Autonomously
functioning Thyroid Adenoma, Secondary pituitary or hypothalamic hypothyroidism, Acute Psychiatric illness, Severe
dehydration.Drugs: Glucocorticoids, Dopamine, Levodopa, T4 replacement therapy, antithyroid drug for thyrotoxicosis.
Pregnancy- first trimester
Increased Levels:
Primary or untreated Hypothyroidism, may vary from 3 times to more than 100 times normal depending on degree of
hypofunction, Hypothyroid patients receiving insufficient thyroid replacement therapy , Hashimoto’s Thyroiditis.
Drugs: Amphetamines, Iodine containing agents and dopamine antagonists. Euthyroid sick syndrome (Recovery phase),
Neonatal period, increased in 1st 2-3 days of life due to postnatal surge,
Limitations:
TSH may be normal in central hypothyroidism, recent rapid correction of hyperthyroidism or hypothyroidism, pregnancy,
phenytoin therapy. Autoimmune disorders may produce spurious results.TSH has a diurnal rhythm so values may vary if
sample collection is done at different times of the day .Age specific reference intervals for TSH from TIETZ Textbook of
CLINICAL CHEMISTRY & MOLECULAR DIAGNOSTICS- 5th Edition

SAMPA
Checked By
DR. S. Bose DR. Swarnendu Pal Dr Sonali Banerjee

MBBS. DCP M.B.B.S., M.D. M.B.B.S., M.D. NABL-M(EL)T-02711

Consultant Histopathologiest & Cytologist Consultant Histopathologist & Cytologist Consultant BioChemist
 NABL ACCREDITED LABORATORY

PANEL
SAMPLE NO
:
:
KANAK NURSING HOME
02/2025/468 OSS *P0140727*
PATIENT NAME : LAKSHI CHAKRABORTY ID NO. : L0140727
SEX / AGE : MALE / 62 Y RECEIPT DATE : 10/02/2025
REFERRED BY : Dr. A PAUL REPORT DATE : 10/02/2025
N.B:-.Reference values represent statistical data for 95% of the population , values outside of these ranges do not
necessarily represent disease rather than classification of patient’s as having disease or being healthy .These reference
may vary depending on the individual laboratory as well as the methods and instruments used . each clinician should
compare the applicability of these data to their own situation .Individual tests are normal in high proportions of patients
with proven specific disease & normal values may not rule out disease .

ALL BLOOD SAMPLES ARE STORED FOR 2 DAYS FROM DATE OF COLLECTION OF SAMPLES. IN CASE OF ANY
DISCREPANCIES REGARDING REPORT PLEASE CONTACT LAB IMMEDIATELY WITHIN 2 DAYS FOR RE-TEST AND
CLARIFICATIONS.
SEROLOGY

Test Name Result Unit Reference Range

C-Reactive Protein(CRP) Test 50.8 mg/L Upto 6.0

Methodology: Turbidimetric
Specimen : Serum
===============================================================================================
======================================
C-reactive protein (CRP) is a special type of protein produced by the liver in response to inflammatory cytokines such as
Interleukin-6 (IL-6). CRP is classified as an acute phase reactant, which means that its levels will rise within a few hours after
tissue injury, the start of an infection, or other cause of inflammation. The most important role of CRP is its interaction with
the complement system, which is one of the body’s immunologic defense mechanisms .
C-reactive protein (CRP) test is performed to determine if a person has a problem linked to acute infection or inflammation.
The CRP test is not diagnostic of any condition, but it can be used together with signs and symptoms and other tests to
evaluate an individual for an acute or chronic inflammatory condition. These include:
To determine if there is infection after surgery: CRP levels normally increase within two to six hours following surgery but then
return to normal by the third day; if CRP levels are elevated three days after surgery it means there is an infection ..
To keep track of an infection or disease that can cause inflammation : Inflammatory bowel disease (IBD), lymphoma ( cancer
of the lymph nodes), immune system diseases such as lupus (SLE), rheumatoid arthritis ( swelling of the tissues that line the
joints) and osteomyelitis (infection of the bone) are some conditions in which inflammation can be monitored with a CRP test .
To monitor treatment of a disease such as cancer or infection : Not only do CRP levels go up quickly if you have an infection
but they also return to normal quickly if you are responding to the treatment.
--------------------------------------------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------

ALL BLOOD SAMPLES ARE STORED FOR 2 DAYS FROM DATE OF COLLECTION OF SAMPLES. IN CASE OF ANY
DISCREPANCIES REGARDING REPORT PLEASE CONTACT LAB IMMEDIATELY WITHIN 2 DAYS FOR RE-TEST AND
CLARIFICATIONS.

Comments : Please Correlate with clinical condition

********** End of Report **********

SAMPA
Checked By
DR. S. Bose DR. Swarnendu Pal Dr Sonali Banerjee

MBBS. DCP M.B.B.S., M.D. M.B.B.S., M.D. NABL-M(EL)T-02711

Consultant Histopathologiest & Cytologist Consultant Histopathologist & Cytologist Consultant BioChemist